Poolbeg expands POLB 001 into oncology
Poolbeg Pharma has announced the strategic expansion of POLB 001 into oncology. POLB 001 is…
January 17, 2023 - 3 minutes
Poolbeg Pharma has announced the strategic expansion of POLB 001 into oncology. POLB 001 is…
Poolbeg Pharma says it has successfully identified potential new drug candidates from its respiratory syncytial…
Poolbeg Pharma has received initial results having completed its lipopolysaccharide (LPS) human challenge clinical trial…
EncOVac, a consortium led by Poolbeg Pharma, has been awarded €2.3m ($2.4 million) in non-dilutive…
Poolbeg Pharma says it has made a breakthrough in its Artificial Intelligence (AI) program with…
Poolbeg Pharma has been granted patents by the US Patent and Trademark Office (USPTO) for…